Plunkett Research Online: Oruka Therapeutics Inc

ORUKA THERAPEUTICS INC (ORKA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome .....



Oruka Therapeutics Inc
Ticker: ORKA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 720 940-2200
Fax: 720 208-9261
Address: 221 Crescent Street
Building 23, Suite 105
Waltham, MA 02453 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description
Lawrence KleinCEO/Director/President
Samarth KulkarniChairman of the Board/Director
See More
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome .....See More See More

Auditor:
Legal Advisor:
Table could not be created because no data was found
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: